Susquehanna Portfolio Strategies »

Perspective Therapeutics shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $52k 13k 4.17

More positions owned by Susquehanna Portfolio Strategies

Merck & Co (MRK)
Micron Technology (MU)
Costco Wholesale Corporation (COST)
Baker Hughes Company Cl A (BKR)
Pfizer (PFE)
Equinix (EQIX)
Lumentum Hldgs (LITE)
Apple (AAPL)
Williams Companies (WMB)
Philip Morris International (PM)
Intel Corporation (INTC)
Medtronic SHS (MDT)
General Motors Company (GM)
TJX Companies (TJX)
Totalenergies Se Act (TTE)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Perspective Therapeutics

TCG Crossover Management
Commodore Capital
Avidity Partners Management
BlackRock
Opaleye Management
Vanguard Capital Management
Millennium Management
Citadel Advisors
Affinity Asset Advisors
State Street Corporation
Balyasny Asset Management
Morgan Stanley
Geode Capital Management
Patient Square Capital
Nicholson Wealth Management Group

View all funds holding Perspective Therapeutics